Yanina Jeanne Leona Jansen (Yanina J L Jansen, Yanina Jansen, Y Jansen)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Epidermal Growth Factor Receptor

Advanced Non Small Cell Lung Cancer

Top Venues

Cancer immunology, immunotherapy : CII

Current oncology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Cedric Vanluyten, Christelle M Vandervelde, Robin Vos, Jan Van Slambrouck, Steffen Fieuws, Paul De Leyn, Philippe Nafteux, Herbert Decaluwé, Hans Van Veer, Lieven P Depypere, Yanina Jeanne Leona Jansen, An-Lies Provoost, Arne P Neyrinck, Catherine M Ingels, Bart M Vanaudenaerde, Laurent Godinas, J Dupont Lieven, Geert M Verleden, Dirk E Van Raemdonck, Laurens J Ceulemans
Lung Transplant Outcome from Selected Older Donors (≥70 Y) Equals Younger Donors (<70 Y): A Propensity-matched Analysis‡. Annals of surgery (2023)
Jan Van Slambrouck, Dirk E Van Raemdonck, Robin Vos, Cedric Vanluyten, Arno Vanstapel, Elena Prisciandaro, Lynn Willems, Michaela Orlitová, Janne Kaes, Xin Jin, Yanina Jeanne Leona Jansen, Geert M Verleden, Arne P Neyrinck, Bart M Vanaudenaerde, Laurens Joseph Ceulemans
A Focused Review on Primary Graft Dysfunction after Clinical Lung Transplantation: A Multilevel Syndrome. Cells 11 (4) (2022)
Yanina Jeanne Leona Jansen, Astrid A M van der Veldt, Gil Awada, Bart Neyns
Anti-PD-1: When to Stop Treatment. Current oncology reports 24 (7) (2022)
Xin Jin, Janne Kaes, Jan Van Slambrouck, Ilhan Inci, Stephan Arni, Vincent Geudens, Tobias Heigl, Yanina Jeanne Leona Jansen, Marianne S Carlon, Robin Vos, Dirk E Van Raemdonck, Yi Zhang, Bart M Vanaudenaerde, Laurens Joseph Ceulemans
A Comprehensive Review on the Surgical Aspect of Lung Transplant Models in Mice and Rats. Cells 11 (3) (2022)
Gil Awada, Yanina Jeanne Leona Jansen, Julia Katharina Schwarze, Jens Tijtgat, Lennert Hellinckx, Odrade Gondry, Sim Vermeulen, Sarah Warren, Kelly Schats, Pieter-Jan van Dam, Mark Kockx, Marleen Keyaerts, Hendrik Everaert, Teofila Seremet, Anne Rogiers, Bart Neyns
A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab. Cancers 13 (2) (2021)
Yanina Jeanne Leona Jansen, Inneke Willekens, Teofila Seremet, Gil Awada, Julia Katharina Schwarze, Johan De Mey, Carola Brussaard, Bart Neyns
Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse. Cancers 13 (3) (2021)
Yanina Jeanne Leona Jansen, Vibeke Kruse, Jurgen Corthals, Kelly Schats, Pieter-Jan van Dam, Teofila Seremet, Carlo Heirman, Lieve Brochez, Mark Kockx, Kris Thielemans, Bart Neyns
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases. Cancer immunology, immunotherapy : CII 69 (12) (2020)
Yanina Jeanne Leona Jansen, Teofila Seremet, Bart Neyns
Pembrolizumab for the treatment of uveal melanoma: A case series. Rare tumors 12 (2020)